顯示第 1 至 16 項結果，共 26 項
-
Anti-Beta-galactosidase [13R4] (Ab00135-10.2-BT)
-
Anti-Beta-galactosidase [13R4] (Ab00135-10.2)
-
Anti-Beta-galactosidase [13R4] (Ab00135-2.2-BT)
-
Anti-Beta-galactosidase [13R4] (Ab00135-2.2)
-
Anti-Beta-galactosidase [13R4] (Ab00135-8.2-BT)
-
Anti-Beta-galactosidase [13R4] (Ab00135-8.2)
-
Anti-EGFR [C225 (Cetuximab)] (Ab00279-10.2-BT)
-
Anti-EGFR [C225 (Cetuximab)] (Ab00279-10.2)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-10.2-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-10.2)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-2.2-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-2.2)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-8.2-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-8.2)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-10.2-BT)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-10.2)